FDA approves world’s most expensive drug at $3.5 million per dose

(Image courtesy Pexels)

(Image courtesy Pexels)

(THE EPOCH TIMES) – The U.S. Food and Drug Administration (FDA) has approved CSL Behring’s hemophilia B gene therapy, a one-off infusion treatment with a list price of $3.5 million, making it the world’s most expensive medicine.

The approval of CSL Behring’s Hemgenix “provides a new treatment option for patients with Hemophilia B and represents important progress in the development of innovative therapies for those experiencing a high burden of disease associated with this form of hemophilia,” said Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research.

WND is now on Trump's Truth Social! Follow us @WNDNews

Hemgenix is used for treating hemophilia B patients who currently use factor IX prophylaxis therapy or suffer from serious spontaneous bleeding episodes or have had a life-threatening hemorrhage. Based on clinical trials, the infusion reduced annual bleeds and “94 percent of patients discontinued factor IX prophylaxis and remained prophylaxis-free,” said the company, opening the possibility for the drug to eliminate the need for lifelong routine treatment in adult patients.

Read the full story ›

The post FDA approves world's most expensive drug at $3.5 million per dose appeared first on WND.

N/A by N/A is licensed under N/A